Increasing Number of Cancer Patients Push Forward the Cancer Monoclonal Antibodies Market in the Forecast Period
According to a new market research report "Cancer Monoclonal Antibodies Market By Application (Liver, Breast, Blood, Brain, Hodgkin's And Non-Hodgkin's Lymphoma, Colorectal, Leukaemia And Others) By Type (murine Antibodies, Chimeric And Humanised Antibodies And Fully Humanized Antibodies) By Conjugated Cancer Therapies - Global Forecast to 2021", published by MarketDataForecast™, the market is expected to reach USD 50 Billion by 2021 from USD 30 Billion in 2016, at a CAGR of 11.2%.
View full press release